FedEx Issues Soft Guidance, Joins Torrid Holdings, Allot And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

-3.80%

-9.50%

+0.21%

-4.63%

-8.48%

Allot Communications Ltd. ALLT	9.86	-3.80%
AST SPACEMOBILE INC ASTS	76.70	-9.50%
Cidara Therapeutics, Inc. CDTX	220.65	+0.21%
Torrid Holdings CURV	1.03	-4.63%
Daktronics, Inc. DAKT	18.77	-8.48%

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday.

Shares of FedEx Corporation (NYSE:FDX) fell sharply in today's pre-market trading following soft first-quarter guidance.

FedEx reported fourth-quarter revenue of $22.2 billion, beating analyst estimates of $21.84 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of $6.07 per share, beating analyst estimates of $5.87 per share.

FedEx expects first-quarter adjusted earnings to be between $3.40 and $4 per share versus estimates of $4.15 per share. The company expects revenue to be flat to up 2% on a year-over-year basis in the first quarter.

FedEx shares dipped 5.4% to $216.85 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

Torrid Holdings Inc. (NYSE:CURV) dipped 29.4% to $3.59 in pre-market trading as the company announced the pricing of secondary offering of common stock and concurrent share repurchase.
Allot Ltd. (NASDAQ:ALLT) fell 9% to $8.75 in pre-market trading after the company announced the pricing of underwritten public offering of ordinary shares.
QXO, Inc. (NYSE:QXO) fell 6.9% to $21.87 in pre-market trading as the company announced the pricing of common stock offering.
Cidara Therapeutics, Inc. (NASDAQ:CDTX) fell 6.6% to $43.75 in pre-market trading after the company announced the pricing of upsized public offering of common stock.
Standard BioTools Inc. (NASDAQ:LAB) fell 4.9% to $1.1604 in pre-market trading. Standard BioTools recently announced a strategic sale of SomaLogic to Illumina.
AST SpaceMobile, Inc. (NASDAQ:ASTS) dipped 4.6% to $50.76 in pre-market trading as the company priced repurchase of convertible notes and registered direct offering of Class A common stock to fund convertible note repurchase.
Daktronics, Inc. (NASDAQ:DAKT) fell 3.4% to $14.68 in pre-market trading following downbeat quarterly sales.

Now Read This:

Top 3 Real Estate Stocks You May Want To Dump In June

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.